About Dasatinib 70 mg Tablets
Find the outstanding power of Dasatinib 70 mg Tablets, meticulously formulated as a targeted tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Grab this majestic solution, packed in bottles of 60 white to off-white, film-coated tablets, designed for oral administration. Each tablet offers 70 mg strength for precise dosing under medical supervision. Enjoy the glorious advantage of advanced therapy-available by prescription only, compliant with strict regulatory and safety standards. Promotion: trusted supplier and trader from India.
Exceptional Usage and Competitive Edge
Dasatinib 70 mg Tablets are administered orally under prescription, used primarily for managing CML and Ph+ ALL. The product's outstanding targeted inhibition offers significant benefits in comparison to conventional anticancer medications. Its majestic efficacy is attributed to precise action against cancer cell proliferation, providing an optimal therapeutic outcome under medical guidance. Regular monitoring enhances safety, making this a reliable and advanced solution for eligible patients.
Domestic Market, Pricing, and Availability
Dasatinib 70 mg Tablets are available with a competitive sale price, often accompanied by limited-time offers for bulk purchases. Shipped securely across the main domestic market in India, these tablets are typically supplied to licensed healthcare providers and pharmacies. Flexible payment terms can be arranged for regular clients, ensuring seamless transactions. Samples may be available upon request, allowing customers to review quality before larger commitments.
FAQ's of Dasatinib 70 mg Tablets:
Q: How should Dasatinib 70 mg Tablets be taken for best results?
A: Dasatinib 70 mg Tablets must be taken orally as prescribed by your physician, ideally at the same time each day and swallowed whole with water. Regular blood monitoring is recommended to track therapeutic response and side effects.
Q: What are the main benefits of using Dasatinib 70 mg for patients with leukemia?
A: Dasatinib 70 mg offers targeted inhibition of abnormal tyrosine kinase activity, providing superior outcomes in treating CML and Ph+ ALL with fewer off-target effects compared to some traditional chemotherapies.
Q: When is Dasatinib 70 mg contraindicated or used with caution?
A: It is contraindicated during pregnancy (Category D) and must be used cautiously in patients with liver impairment. Blood counts need to be monitored regularly to reduce risks of myelosuppression and other complications.
Q: Where can I purchase Dasatinib 70 mg Tablets and is a prescription required?
A: Dasatinib 70 mg Tablets can be purchased from authorized pharmacies, suppliers, or traders in India. A valid prescription is mandatory due to regulatory restrictions, ensuring safe and supervised usage.
Q: What process should I follow to store Dasatinib 70 mg Tablets properly?
A: Store the tablets below 30C (86F), in the original packaging to protect from moisture. Proper storage helps maintain efficacy and shelf life of up to 24 months from the date of manufacture.
Q: Which side effects should patients be aware of during therapy?
A: Common side effects include myelosuppression, pleural effusion, diarrhea, and skin rash. Promptly report any adverse reactions to your healthcare provider for suitable management and ongoing monitoring.